Is Nutrien stock a Buy, Sell or Hold?
Nutrien stock has received a consensus rating of buy. The average rating score is and is based on 20 buy ratings, 16 hold ratings, and 5 sell ratings.What was the 52-week low for Nutrien stock?
The low in the last 52 weeks of Nutrien stock was 68.82. According to the current price, Nutrien is 105.65% away from the 52-week low.What was the 52-week high for Nutrien stock?
The high in the last 52 weeks of Nutrien stock was 117.22. According to the current price, Nutrien is 62.03% away from the 52-week high.What are analysts forecasts for Nutrien stock?
The 41 analysts offering price forecasts for Nutrien have a median target of 92.56, with a high estimate of 135.00 and a low estimate of 62.00. The median estimate represents a 78.55 difference from the last price of 72.71.Nutrien Stock Snapshot
72.69
Bid
4,600.00
Bid Size
72.70
Ask
1,300.00
Ask Size
3/17/2023
Date
4:15 PM
Time
473,581.00
Volume
72.68
Prev. Close
72.02
Open
38.18 B
Market Cap
520.18 M
Number of Shares
71.66
Day Low
73.11
Day High
72.71
68.82
52 Week Low
117.22
52 Week High
72.71
2.69
Dividend
2.58
Dividend Yield
5.59
P/E Ratio
99.96
Free Float in %
12.75
EPS 2023
73.63
Book Value per Share
17.99
Cash Flow per Share
Nutrien News More News
Nutrien Historical Prices
Date | Open | Close | Daily High | Daily Low |
---|
Price change over selected period:
0%
0
Nutrien Analyst Data
Total Analysts: 41
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price
*Price Target
Lowest: 62.00
Median: 92.56
Highest: 135.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.
Nutrien Analyst Opinions
- All
- Buy
- Hold
- Sell
02/21/23 | RBC Capital Markets | Maintained Buy | $110 | ||
02/21/23 | HSBC | Maintained Sell | $81 | ||
02/17/23 | Wells Fargo & Co | Maintained Hold | $82 | ||
02/16/23 | UBS | Maintained Buy | $100 | ||
02/16/23 | Credit Suisse | Maintained Sell | $70 | ||
02/08/23 | TD Securities | Downgraded to Hold | |||
02/03/23 | Raymond James Financial, Inc. | Downgraded to Hold | |||
01/30/23 | RBC Capital Markets | Maintained Buy | $115 | ||
01/20/23 | Citigroup Corp. | Maintained Buy | $86 | ||
01/19/23 | Wells Fargo & Co | Maintained Hold | $80 | ||
01/12/23 | Mizuho | Maintained Hold | $91 | ||
01/11/23 | UBS | Maintained Buy | $103 | ||
01/11/23 | Morgan Stanley | Maintained Hold | $91 | ||
01/09/23 | Credit Suisse | Maintained Sell | |||
11/30/22 | Piper Sandler | Downgraded to Hold | $93 | ||
11/07/22 | RBC Capital Markets | Maintained Buy | $120 | ||
11/04/22 | Mizuho | Maintained Hold | $93 | ||
11/04/22 | BMO Capital Markets | Maintained Buy | $110 | ||
11/03/22 | Credit Suisse | Maintained Sell | $68 | ||
11/01/22 | Mizuho | Maintained Hold | $113 | ||
08/10/22 | Barclays Capital | Maintained Buy | $105 | ||
08/04/22 | Credit Suisse | Maintained Sell | $70 | ||
07/14/22 | Credit Suisse | Maintained Sell | $67 | ||
05/31/22 | Piper Sandler | Maintained Buy | $125 | ||
04/29/22 | Mizuho | Maintained Hold | $124 | ||
04/21/22 | RBC Capital Markets | Maintained Buy | $135 | ||
03/22/22 | Citigroup Corp. | Maintained Buy | $126 | ||
03/17/22 | Morgan Stanley | Maintained Hold | $100 | ||
03/16/22 | Goldman Sachs | Maintained Buy | $121 | ||
03/07/22 | Piper Sandler | Upgraded to Buy | $112 | ||
03/01/22 | Stifel, Nicolaus & Co., Inc. | Maintained Buy | $100 | ||
02/22/22 | RBC Capital Markets | Maintained Buy | $90 | ||
02/18/22 | Atlantic Equities | Upgraded to Hold | $79 | ||
02/15/22 | Mizuho | Maintained Hold | $87 | ||
01/04/22 | UBS | Maintained Buy | $93 | ||
12/17/21 | Piper Sandler | Maintained Hold | $80 | ||
11/04/21 | Mizuho | Maintained Hold | $75 | ||
10/13/21 | Mizuho | Maintained Hold | $70 | ||
10/07/21 | RBC Capital Markets | Maintained Buy | $80 | ||
06/29/21 | Susquehanna Financial Group, LLLP | Upgraded to Buy | $70 | ||
06/16/21 | Morgan Stanley | Maintained Hold | $68 | ||
06/15/21 | Raymond James Financial, Inc. | Downgraded to Buy | $82 | ||
05/24/21 | HSBC | Upgraded to Buy | $68 | ||
05/10/21 | Morgan Stanley | Maintained Hold | $62 |
Nutrien Estimates* in CAD
2023 | 2024 | 2025 | 2026 | |
---|---|---|---|---|
Revenue | 43,463 | 41,745 | 41,468 | 47,224 |
Dividend | 2.69 | 2.79 | 2.82 | - |
Dividend Yield (in %) | 2.58 % | 2.67 % | 2.70 % | 1.29 % |
EPS | 12.75 | 11.23 | 10.66 | 12.09 |
P/E Ratio | 7.83 | 8.89 | 9.37 | 8.26 |
EBIT | 9,311 | 7,966 | 7,352 | 7,981 |
EBITDA | 12,112 | 10,894 | 10,137 | 10,767 |
Net Profit | 6,390 | 5,426 | 4,907 | 5,628 |
Net Profit Adjusted | 6,479 | 5,428 | 4,762 | 3,384 |
Pre-Tax Profit | 8,422 | 7,078 | 6,354 | 7,421 |
Net Profit (Adjusted) | 8,189 | 7,030 | 5,858 | - |
EPS (Non-GAAP) ex. SOE | 12.75 | 11.23 | 10.66 | 12.09 |
EPS (GAAP) | 12.72 | 10.92 | 10.14 | - |
Gross Income | 15,889 | 14,728 | 14,809 | 16,541 |
Cash Flow from Investing | -3,607 | -3,489 | -3,430 | -2,968 |
Cash Flow from Operations | 10,130 | 8,590 | 8,305 | 8,635 |
Cash Flow from Financing | -4,575 | -3,661 | -3,647 | -1,889 |
Cash Flow per Share | 17.99 | 17.03 | 15.40 | - |
Free Cash Flow | 6,437 | 5,669 | 4,655 | 5,725 |
Free Cash Flow per Share | 12.49 | 11.34 | 10.83 | 11.02 |
Book Value per Share | 73.63 | 79.86 | 83.78 | - |
Net Debt | 12,599 | 11,008 | 10,225 | 4,466 |
Research & Development Exp. | - | - | - | - |
Capital Expenditure | 3,411 | 3,059 | 2,705 | 2,699 |
Selling, General & Admin. Exp. | 4,094 | 3,995 | 4,486 | - |
Shareholder’s Equity | 37,281 | 39,710 | 41,273 | 53,565 |
Total Assets | 73,482 | 75,010 | 79,691 | 92,289 |
Previous Quarter ending 12/31/22 |
Current Quarter ending 03/31/23 |
Next Quarter ending 06/30/23 |
Current Year ending 12/31/23 |
Next Year ending 12/31/24 |
|
---|---|---|---|---|---|
Earnings Estimates | |||||
No. of Analysts | 18 | 17 | 17 | 22 | 22 |
Average Estimate | 3.443 CAD | 2.261 CAD | 5.226 CAD | 12.753 CAD | 11.226 CAD |
Year Ago | 3.136 CAD | 3.470 CAD | 7.521 CAD | 17.743 CAD | 12.753 CAD |
Publish Date | 2/15/2023 | 5/10/2023 | 8/2/2023 | - | - |
Revenue Estimates | |||||
No. of Analysts | 13 | 13 | 13 | 21 | 20 |
Average Estimate | 10,039 CAD | 8,947 CAD | 16,226 CAD | 43,463 CAD | 41,745 CAD |
Year Ago | 8,976 CAD | 9,581 CAD | 18,365 CAD | 49,789 CAD | 43,463 CAD |
Publish Date | 2/15/2023 | 5/10/2023 | 8/2/2023 | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Nutrien Dividend Calendar
Date | Name | Dividend | *yield | Currency |
---|---|---|---|---|
2022 | Nutrien (Ex Potash Agrium) | 2.52 | 2.55 | CAD |
2021 | Nutrien (Ex Potash Agrium) | 2.32 | 2.44 | CAD |
2020 | Nutrien (Ex Potash Agrium) | 2.43 | 3.97 | CAD |
2019 | Nutrien (Ex Potash Agrium) | 2.32 | 3.74 | CAD |
2018 | Nutrien (Ex Potash Agrium) | 2.15 | 3.36 | CAD |
2017 | Nutrien (Ex Potash Agrium) | - | - | CAD |
*Yield of the Respective Date
Nutrien (Ex Potash Agrium) Calendar
Event | Estimate | Info | Date |
---|---|---|---|
Earnings Report | 2.261 CAD | Q1 2023 Earnings Release | 05/10/2023 |
Annual General Meeting | - | Annual General Meeting | 05/10/2023 |
Earnings Report | 5.226 CAD | Q2 2023 Earnings Release | 08/02/2023 |
Earnings Report | - | Q3 2023 Earnings Release | 11/01/2023 |
Earnings Report | - | Q4 2023 Earnings Release | 02/14/2024 |
Earnings Report | - | Q1 2024 Earnings Release | 05/08/2024 |
Earnings Report | - | Q2 2024 Earnings Release | 07/31/2024 |
Earnings Report | - | Q3 2024 Earnings Release | 11/04/2024 |
Nutrien (Ex Potash Agrium) Past Events
Event | Actual EPS | Info | Date |
---|---|---|---|
Earnings Report | 2.717 CAD | Q4 2022 Earnings Release | 02/15/2023 |
Press Conference | - | - | 08/04/2022 |
Nutrien Profile
Nutrien Ltd. is a crop nutrient company, which engages in the production and distribution of products for agricultural, industrial, and feed customer. It operates through the following segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seed, and merchandise. The Potash, Nitrogen, and Phosphate segments produces differentiated chemical nutrient contained in each products. The company was founded on June 2, 2017 and is headquartered in Saskatoon, Canada.
Moody’s Daily Credit Risk Score
Nutrien Shareholder
Owner | in % |
---|---|
Freefloat | 99.96 |
T. Rowe Price Associates, Inc. (Investment Management) | 4.23 |
Vanguard Group, Inc. (Subfiler) | 2.37 |
Capital Research & Management Co. (International Investors) | 2.33 |
DWS Investment GmbH | 2.22 |
Fidelity Management & Research Co. LLC | 2.16 |
RBC Dominion Securities, Inc. | 2.15 |
Mackenzie Financial Corp. | 2.15 |
Dodge & Cox | 2.07 |
Fidelity Investments Canada ULC | 2.06 |
RBC Global Asset Management, Inc. | 1.97 |
Managed Account Advisors LLC | 1.64 |
First Eagle Investment Management LLC | 1.64 |
Dodge & Cox International Stock Fund | 1.50 |
DWS Top Dividende | 1.40 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.